Earnings FeedTerminal

⌘K

Home/Filings/6-K/0001213900-25-112853

6-K//Foreign company update

Clearmind Medicine Inc. 6-K

Accession 0001213900-25-112853

$CMNDCIK 0001892500other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 8:08 AM ET

Size

25.6 KB

Accession

0001213900-25-112853

Documents

3 files

6-K
ea0266569-6k_clearmind.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
EX-99.1
ea026656901ex99-1_clearmind.htm
PRESS RELEASE TITLED: "CLEARMIND MEDICINE ACCELERATE FDA-APPROVED ALCOHOL USE DISORDER CLINICAL TRIAL BY ACTIVATING FIFTH ELITE GLOBAL MEDICAL SITE"
GRAPHIC
ex99-1_001.jpg
GRAPHIC

Issuer

Clearmind Medicine Inc.

CIK 0001892500

Entity typeother

IncorporatedCanada (Federal Level)

Related Parties

1

filerCIK 0001892500

Filing Metadata

Form type: 6-K
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 8:08 AM ET
Size: 25.6 KB

View on SEC.gov